CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shasun Pharmaceuticals Ltd (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shasun Pharmaceuticals Ltd (Parent)
28, Batra Centre, 3rd & 4th Floor
Sardar Patel Road, Guindy
Phone: +91 4443446700p:+91 4443446700 CHENNAI, 600032  India Fax: +91 4422350278f:+91 4422350278
Business Summary
Shasun Pharmaceuticals Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), their intermediates and formulations. The Company is a manufacturer and supplier of Ibuprofen and Ibuprofen derivatives. It offers a range of products in the areas of pain management, anti ulcerants and central nervous system (CNS). It offers services from the discovery stage to commercial manufacture and formulations. Its products and services include contract research and manufacturing services, formulation, biotech, project management, product database, technologies, hazard evaluation, engineering, supply chain and biological treatment. Its contract research and manufacturing service includes chemistry services and analytical services. It offers technology services, which include chiral technologies and fluorination. It offers APIs for pain management and musculoskeletal, cardiovascular, anti-infective, gastrointestinal and cough suppressants, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20153/31/2015Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer S.Hariharan 4/20/2011 2/23/2011
Compliance Officer, Company Secretary S. MuraliKrishna 4/20/2011 4/20/2011
Managing Director, Whole Time Director S. AbhayaKumar 59 4/1/2011 10/19/2006
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,500 (As of 3/31/2012)
Outstanding Shares: 67,255,452 (As of 10/13/2015)
Shareholders: 19,744
Fax Number: +91 4422350278


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023